Purine nucleoside phosphorylase gene therapy

N/A

Report date: 2023/10/26 16:56:45

Base Information

Drug NamePurine nucleoside phosphorylase gene therapy
Drug Alias NameAdenovirus/PNPGedeptinAd/PNP
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of AlabamaSouthern Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesGeovax Inc
Inactive CompaniesPnp Therapeutics Inc
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A